| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AMGEN INC | EVP, R&D, & Chief Sci. Officer | Common Stock | 29.8K | $9.27M | $311.55 | May 6, 2025 | Direct |
| AMGEN INC | EVP, R&D, & Chief Sci. Officer | Nqso (Right to Buy) | 22.9K | $6.2M | $270.44 | May 6, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| AMGN | AMGEN INC | May 6, 2025 | 2 | $6.2M | 4 | May 8, 2025 | EVP, R&D, & Chief Sci. Officer |
| AMGN | AMGEN INC | May 7, 2024 | 2 | $5.59M | 4 | May 9, 2024 | EVP, R&D, & Chief Sci. Officer |
| AMGN | AMGEN INC | Feb 9, 2024 | 2 | $0 | 4 | Feb 12, 2024 | EVP, R&D, & Chief Sci. Officer |
| AMGN | AMGEN INC | Dec 18, 2023 | 0 | $0 | 3 | Dec 19, 2023 | EVP, R&D, & Chief Sci. Officer |